HEARTSAVERS METHODOLGY
​
The HEARTSAVERS methodology CALCULATES THE SEVERITY of the Cardiovascular Disease and recommends PERSONALIZED EARLY TREATMENT
​
Our TEST is designed to be FAST, RELIABLE and COMFORTABLE to the patient, with no radiation or invasive techniques
​
Our TREATMENT RECOMMENDATION is based on accumulated EXPERTISE and constantly EVOLVING with the progress in Medical Sciences.
CARDIOVASCULAR DISEASE is GRADUAL
A HEARTSAVERS TEST can help you to DETECT and TREAT it EARLY
HEARTSAVERS is committed to bringing continuous scientific innovations to both the screening methodology and treatment recommendations thanks to our innovation partners
THE METHODOLOGY HAS BEEN SUBJECT TO NUMEROUS LARGE SCALE LONG TERM LONGITUDINAL TRIALS
-
– MESA 2000-2008 study (Duprez et al, 2011, n=6,500)
-
– Artery Elasticity (Cohn et al, 2003, n=396)
-
– Outperformance to Framingham Risk Score (Duprez et al, 2011, n=633)
-
– Rasmussen Study 2000-2015 (Duprez et al, 2020, n=1,900)
​
Our evidence-based data collection continues from patients in our different clinics and is periodically ​utilized
in ongoing research and new publications
​
​
HEARTSAVERS SCIENTIFIC FOUNDERS
The Science behind HeartSavers originates from the Rasmussen Center for Cardiovascular
Prevention at the University of Minnesota in Minneapolis
https://www.mhealthfairview.org/locations/m-health-fairview-clinic--- rasmussen-center
The HeartSavers methodology has originally been developed by Dr Jay Cohn
CO-FOUNDER
HEAD EXPERT
HEARTSAVERS GLOBAL
and Dr Mafhouz Al-Shahawy at the Cardiovascular Center of Sarasota and many others.
HEARTSAVERS EXPERT
SARASOTA MEMORIAL HOSPITAL
HEARTSAVERS SCIENTIFIC ADVISORS IN SWITZERLAND
Dr. Georg Ehret, Hopital Universitaire de Geneve https://www.unige.ch/medecine/demed/fr/groupes-de-recherche/901ehret/membres/ehret/
​
Dr. Thilo Burkard, UniversitatsSpital Basel https://www.unispital-basel.ch/ueber- uns/departemente/akutmedizin/kliniken/medizinische-poliklinik/ueber-uns/leitung/pers/thilo-burkard/
Dr. Annina Vischer, UniversitatsSpital Basel https://www.unispital-basel.ch/ueber- uns/departemente/akutmedizin/kliniken/medizinische-poliklinik/ueber-uns/abteilungen/pers/annina-vischer/
Prof. Dr. Isabella Sudano, UniversitatsSpital Zurich https://www.usz.ch/team/isabella-sudano/
Prof. Dr. Augusto Gallino, Ente Ospedaliero Cantonale Bellinzona https://www.eoc.ch/Dettagli/Medico.Gallino--Augusto.47.html
HEARTSAVERS SCIENCE BASIS AND CLINICAL TRIALS
The HEARTSAVERS Methodology has been the subject of thorough research and optimization over the last 2 decades. The following publications are the basis of the scientific rationale and describe the results of the major clinical trials that implemented the methodology.
-
Early cardiovascular structural and functional abnormalities as a guide to future morbid events. Duprez D, Duval S, Hoke L, Florea N, Grandits G, Carlson C, Lee J, Cohn J; European Journal of Prevention Cardiology 2020
-
Early cardiovascular structural and functional abnormalities as a guide to future morbid events – Editorial. Koskinen J, Raitakari O; European Journal of Prevention Cardiology 2020
-
Association of Small Artery Elasticity With Incident Cardiovascular Disease in Older Adults. The Multi- Ethnic Study of Atherosclerosis (MESA). Duprez D, Jacobs D, Lutsey P, Bluemke D, Brumback L, Polak J, Peralta C, Greenland P, Kronmal R; American Journal of Epidemology 2011
-
Identifying the Risks and Preventing the Consequences of Cardiovascular Disease. Cohn J, ANZCTS and CSANZ, 2013
-
Arterial Elasticity as Part of a Comprehensive Assessment of CVD Risk and Drug Treatment. Cohn J, Duprez D, Grandits G; Hypertension 2005
-
Comprehensive noninvasive arterial vascular evaluation. Cohn J, Duprez D, Finkelstein S; Future Cardiology 2009
-
Cardiovascular Disease Progression : A Target for Therapy? Cohn J; The American Journal of Medicine 2018
-
How do we improve Patient Compliance and Adherence to Long-Term Statin Therapy? Maningat P, Gordon B, Breslow J, Current Atherosclerosis Reports, 2013